Equiduct in talks to take on Nasdasq OMX Neuro business

Equiduct in talks to take on Nasdasq OMX Neuro business

European electronic exchange venue Equiduct has moved to take advantage of Nasdaq OMX's decision to shut its Neuro MTF, entering into exclusive talks to migrate clients to its platform.

On Wednesday Nasdaq OMX outlined plans to close Neuro down, admitting defeat in its attempts to conquer the fiercely competitive post-Mifid European market. The last day of trading is expected to be 21 May.

The exchange giant has now agreed to exclusive talks on giving Neuro's 40-plus clients the option of migrating their flow to the Equiduct platform using their existing connections.

Charlotte Crosswell, president, Neuro, says: "We are pleased to be working with Equiduct to allow Neuro clients to continue to effectively utilize their connectivity to the platform."

Peter Randall, CEO, Equiduct, adds: "Our top priority is to provide clients with the seamless ability to move from one platform to another. We will be working closely with Neuro and its clients to meet this goal in the coming weeks."

Comments: (0)